Targeting tau degradation: a viable therapeutic approach?
Targeting tau degradation: a viable therapeutic approach?
About this item
Full title
Author / Creator
Publisher
England: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
The causes of tau filament formation are unclear, but model systems suggest that filament formation is reduced by lowering the intracellular concentration of tau. [...]while clinical trials of treatments for Alzheimer's disease are aimed at delaying disease progression by clearing amyloid-β plaques, parallel efforts are focusing on tau-reduction st...
Alternative Titles
Full title
Targeting tau degradation: a viable therapeutic approach?
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2798714412
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2798714412
Other Identifiers
ISSN
1474-4422
E-ISSN
1474-4465
DOI
10.1016/S1474-4422(23)00108-4
